Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence R Wilson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Systematic Reviews|November 16, 2018
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysisFlorence R Wilson, Megan E Coombes, Christine Brezden-Masley, et al.
Advances in Therapy|February 28, 2026
Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid LeukemiaJustin M Watts, Eunice S Wang, Brian A Jonas, et al.
Therapeutic Advances in Medical Oncology|June 24, 2022
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50Nick Freemantle, Yingxin Xu, Florence R Wilson, et al.
Frontiers in Oncology|April 21, 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancerJosephine Louella Feliciano, Dylan McLoone, Yingxin Xu, et al.
Cancers|April 14, 2025
Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature ReviewBenjamin Derman, Carlyn Tan, Ian Steinfield, et al.
Journal of Comparative Effectiveness Research|November 3, 2020
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancerSam T Keeping, Shannon Cope, Keith Chan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Systematic Reviews|November 16, 2018
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysisFlorence R Wilson, Megan E Coombes, Christine Brezden-Masley, et al.
Advances in Therapy|February 28, 2026
Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid LeukemiaJustin M Watts, Eunice S Wang, Brian A Jonas, et al.
Therapeutic Advances in Medical Oncology|June 24, 2022
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50Nick Freemantle, Yingxin Xu, Florence R Wilson, et al.
Frontiers in Oncology|April 21, 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancerJosephine Louella Feliciano, Dylan McLoone, Yingxin Xu, et al.
Cancers|April 14, 2025
Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature ReviewBenjamin Derman, Carlyn Tan, Ian Steinfield, et al.
Journal of Comparative Effectiveness Research|November 3, 2020
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancerSam T Keeping, Shannon Cope, Keith Chan, et al.
Pageof 2